Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including oligodendrocytes; strongest in retinal horizontal cells | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 2 Parkinson's papers of 52 | 0.85 |
| pathways Reactome | 2 pathways; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 6808
Sealed predictions
- SEPTIN4 in oligodendrocytes, braakn/a → n/areceipt 6815
- SEPTIN4 in dopamine neurons, braakn/a → n/areceipt 6816
Swarm cases
receipt 6816: SEPTIN4 in dopamine neurons, braak
- cell type
- SEPTIN4 is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SEPTIN4 in dopamine neurons.
case closed: nothing better to follow up.
receipt 6815: SEPTIN4 in oligodendrocytes, braak
- cell type
- SEPTIN4 is not measured in oligodendrocytes; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SEPTIN4 in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts